# Topical Anesthesia and Intra-arterial Chemotherapy for Retinoblastoma

> **NCT02955524** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of Miami**

## Conditions studied

- Hemodynamic Instability

## Interventions

- **DRUG:** Tetracaine 0.5%
- **DRUG:** Lidocaine hydrochloride ophthalmic gel 3.5%

## Key facts

- **NCT ID:** NCT02955524
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-03
- **Primary completion:** 2020-06
- **Final completion:** 2020-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** I discontinued this study because I transferred to another institution.
- **Last updated:** 2018-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02955524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02955524, "Topical Anesthesia and Intra-arterial Chemotherapy for Retinoblastoma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02955524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*